Companion Diagnostics Market is projected to witness growth at a CAGR of 20.0% during the forecast period of 2022-2030
The global companion diagnostics market is projected to
witness growth at a CAGR of 20.0% during the forecast period of 2022-2030.
A companion diagnostic is an in vitro medical gadget that
is used in conjunction with a therapeutic drug to evaluate the medicine's
efficacy and applicability on patients. It employs a combination of tests and
therapies to provide essential information on related therapeutic
pharmaceuticals or biological products, allowing for the safe and effective
delivery of medical care. These diagnostics also give medical practitioners a
better grasp of disease biology and mechanism of action (MOA), which helps them
assess the potential side effects or hazards of a treatment product on specific
human bodies.
Download
Request for Sample@ https://bit.ly/3O5HL8V
GROWTH DRIVERS:
Furthermore, since the previous few decades, the number
of cancer cases of various types has been increasing at an unprecedented rate
around the world. According to a new estimate, by 2030, the worldwide cancer
burden is expected to climb to almost 22.0 million new cancer cases (with
around 13.0 million cancer deaths). Companion diagnostics is widely used to
improve the predictability of the medication development process in oncology.
As a result, rising cancer occurrences are projected to drive the adoption of
companion diagnostics for the quick development of cancer therapy medications.
In addition, the number of FDA-approved cancer diagnostic tests is increasing,
giving the worldwide companion diagnostics market a boost.
Furthermore, the number of partnerships and collaborations
between market leaders for the development of novel companion diagnostics
products is rapidly increasing. Collaborations between firms to produce
improved biomarkers and diagnostics are expected to provide enough potential
for the global companion diagnostics market to flourish in the future years.
COMPANION DIAGNOSTICS
MARKET SEGMENTATION:
By Product &
Services:
· Assay
Kits & Reagents
· Software
& Services
By Technology:
· Polymerase
Chain Reaction (PCR)
· In
Situ Hybridization (ISH)
· Next-Generation
Sequencing (NGS)
· Immunohistochemistry
(IHC)
· Others
By Indication:
· Cardiovascular
· Neurological
Diseases
· Cancer
§
Breast Cancer
§
Lung Cancer
§
Colorectal Cancer
§
Melanoma
§
Gastric Cancer
§
Infectious Diseases
§
Others
By End User:
· Pharmaceutical
& Biopharmaceutical Companies
· Reference
Laboratories
· Contract
Research Organizations
· Others
By Region:
· North
America
· Europe
· Asia
Pacific
· Latin
America
· Middle
East & Africa
The assay kits & reagents segment is expected to
account for the biggest market share in the companion diagnostics market during
the forecast period, based on products and services. The rapidly rising need
for high-performance diagnostics kits in clinical trials and commercial
applications, as well as expanding innovations in sample processing, are
driving the segment's expansion.
In 2020, the polymerase chain reaction (PCR) category
accounted for the highest share of the worldwide companion diagnostics market
in terms of technology. Over the forecast period, the segment is expected to
maintain its market dominance.
The cancer sector accounted for the biggest proportion of
the worldwide companion diagnostics market in 2020, and this trend is projected
to continue during the forecast period.
In 2020, the pharmaceutical and biopharmaceutical
industries sector dominated the companion diagnostics market by end-user. Over
the forecast term, the tendency is expected to continue. The key element linked
to the segment's growth is the massively increasing application of companion
diagnostics in these companies due to their growing relevance in medication
development.
KEY COMPANIES IN
COMPANION DIAGNOSTICS MARKET:
· Hoffmann-La
Roche AG
· Agilent
Technologies Inc.
· Biogenex
Laboratories Inc.
· Abbott
Laboratories Molecular Inc.
· ARUP
Laboratories Inc.
· BioMerieux
SA
· Danaher
Corporation
· Foundation
Medicine Inc.
· Almac
Group
· Sysmex
Corporation
· Thermo
Fisher Scientific Inc.
· Abnova
Corporation
· Guardant
Health Inc.
· Icon
Plc
· Myriad
Genetics Inc.
· Qiagen
N.V.
Read
More Information: https://www.xresearch.biz/shop/companion-diagnostics-market
About
Us:-
xResearch is a market
research and consulting organization that uses unique data, expert analysis,
and new technologies to create trusted intelligence on industries. Our research
is focused on delivering an informed and impartial view on essential market
data of industry, and it is primarily driven by an in-depth study covering the
following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-618-4545

Comments
Post a Comment